Corrigendum to “Synthesis and clinical application of new drugs approved by NMPA in 2023” [European Journal of Medicinal chemistry 283 (2025) 117181/EJMECH-d-24-03758]

Lijuan Xie, Yingying Wang, Kunyu Wang, Wanying Chen, Fuwei Yang

Open source

DOI
10.1016/j.ejmech.2025.117853
Published
2025-10
Container
European Journal of Medicinal Chemistry
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejmech.2025.117853,
  title = {Corrigendum to “Synthesis and clinical application of new drugs approved by NMPA in 2023” [European Journal of Medicinal chemistry 283 (2025) 117181/EJMECH-d-24-03758]},
  author = {Lijuan Xie and Yingying Wang and Kunyu Wang and Wanying Chen and Fuwei Yang},
  year = {2025},
  journal = {European Journal of Medicinal Chemistry},
  doi = {10.1016/j.ejmech.2025.117853},
  url = {https://doi.org/10.1016/j.ejmech.2025.117853}
}

RIS

TY  - JOUR
TI  - Corrigendum to “Synthesis and clinical application of new drugs approved by NMPA in 2023” [European Journal of Medicinal chemistry 283 (2025) 117181/EJMECH-d-24-03758]
AU  - Lijuan Xie
AU  - Yingying Wang
AU  - Kunyu Wang
AU  - Wanying Chen
AU  - Fuwei Yang
PY  - 2025
JO  - European Journal of Medicinal Chemistry
DO  - 10.1016/j.ejmech.2025.117853
UR  - https://doi.org/10.1016/j.ejmech.2025.117853
ER  - 

APA

Xie, L., Wang, Y., Wang, K., Chen, W., & Yang, F. (2025). Corrigendum to “Synthesis and clinical application of new drugs approved by NMPA in 2023” [European Journal of Medicinal chemistry 283 (2025) 117181/EJMECH-d-24-03758]. European Journal of Medicinal Chemistry. https://doi.org/10.1016/j.ejmech.2025.117853

Source records